Cambridge Investment Research Advisors Boosts McKesson Co. Position
December 30, 2022
Trending News ☀️
Mckesson Corporation Intrinsic Value – MCKESSON ($NYSE:MCK): The company provides pharmacy automation, medical supplies, software, and other services to health systems, pharmacies, manufacturers, and providers. McKesson’s stock is traded on the New York Stock Exchange under the symbol MCK. Cambridge Investment Research Advisors Inc., a financial services firm, has recently made a significant investment in McKesson Co. This increase in its position has caused the stock to rise significantly and benefit shareholders. The investment by Cambridge Investment Research Advisors Inc. is an indication of their confidence in McKesson Co.’s future prospects. The company’s stock has been performing well since the investment and analysts are optimistic that the trend will continue.
The company’s strong fundamentals, such as its strong balance sheet, have been a major contributor to its success. The increase in the McKesson Co.’s position is indicative of the confidence investors have in the company’s performance. It is likely that the company’s stock will continue to rise and benefit shareholders as the market continues to favor healthcare stocks. With the recent investment from Cambridge Investment Research Advisors Inc., investors can be assured that their investments are in good hands.
Market Price
Currently, media sentiment for the company is mostly positive. On Tuesday, MCKESSON CORPORATION opened at $384.7 and closed at $380.2, a decrease of 0.9% from its prior closing price of $383.7. This decrease could be due to the fact that the overall market was down on Tuesday, as well as a lack of positive news regarding the company’s financials or operations. Despite this decrease, investors remain optimistic about the company’s future prospects. Analysts and investors alike are drawn to MCKESSON CORPORATION due to its strong and diverse portfolio of healthcare products and services. The company has a presence in both the pharmaceutical and medical supplies sectors, providing a wide range of products and services to customers and clients around the world.
Additionally, the company has a strong management team that has consistently delivered on its financial goals and objectives. Looking ahead, analysts expect MCKESSON CORPORATION to continue to post strong financial results and remain a leader in its industry. With the recent boost from Cambridge Investment Research Advisors Inc., investors are optimistic that the stock will continue to perform well in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Mckesson Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 272.03k | 2.06k | 0.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Mckesson Corporation. More…
| Operations | Investing | Financing |
| 4.43k | 184 | -4.18k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Mckesson Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 63.08k | 64.33k | -12.46 |
Key Ratios Snapshot
Some of the financial key ratios for Mckesson Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.0% | 2.4% | 1.2% |
| FCF Margin | ROE | ROA |
| 1.5% | -111.3% | 3.3% |
VI Analysis – Mckesson Corporation Intrinsic Value
MCKESSON CORPORATION is a company that has long term potential, as evidenced by its fundamentals. VI app simplifies the process of analyzing the company’s fundamentals to determine its intrinsic value. According to the VI Line, MCKESSON CORPORATION’s intrinsic value is estimated to be around $260.8 per share. Currently, the stock is trading at $380.2, which is 46% higher than the intrinsic value. This suggests that the stock is overvalued in the market. Investors should be aware of this disparity between the intrinsic value and current stock price before investing in MCKESSON CORPORATION. Investors should also consider the company’s financial performance, competitive advantage and other factors before investing. Additionally, investors should pay attention to the stock market’s volatility in order to minimize the risk of loss. Although MCKESSON CORPORATION is currently overvalued, it may still make sense for investors with a long-term outlook to invest in the company given its strong fundamentals. This would allow them to benefit from the company’s potential for growth and profit over the long term. Ultimately, investors must make their own decisions regarding whether or not to invest in MCKESSON CORPORATION based on their own research and analysis. More…
VI Peers
In the healthcare sector, McKesson Corp competes against Cardinal Health Inc, AmerisourceBergen Corp, and Sigma Healthcare Ltd. These companies are all major players in the healthcare industry, and each one brings something unique to the table. However, McKesson Corp is the largest of these companies, and its size gives it a significant competitive advantage.
– Cardinal Health Inc ($NYSE:CAH)
Cardinal Health Inc is a healthcare services and products company that operates in two segments: Pharmaceutical and Medical. The company’s Pharmaceutical segment includes sales of branded, generic and over-the-counter pharmaceutical products, as well as nuclear pharmacy services. The Medical segment provides a range of medical products and services, including surgical and medical products, medical devices and laboratory products and services. Cardinal Health Inc has a market cap of 18.55B as of 2022. The company’s Return on Equity for the same period is 55.12%.
– AmerisourceBergen Corp ($NYSE:ABC)
AmerisourceBergen is one of the world’s largest pharmaceutical services companies. It offers a range of services and products to healthcare providers and pharmaceutical companies. The company has a market cap of 29.64B as of 2022 and a return on equity of 417.0%. AmerisourceBergen is a publicly traded company listed on the New York Stock Exchange.
– Sigma Healthcare Ltd ($ASX:SIG)
Sigma Healthcare is a leading full-line wholesale and distribution company that services pharmacies across Australia. The company has a market capitalisation of $693.83 million as of March 2022 and a return on equity of 0.46%. Sigma Healthcare is a diversified healthcare company with operations in both pharmacy and hospital sectors. The company’s primary activities include the wholesale distribution of pharmaceuticals, medical and surgical supplies. Sigma Healthcare also owns and operates a number of community pharmacies across Australia.
Summary
McKesson Corporation has been the subject of recent investment analysis, as Cambridge Investment Research Advisors Inc. has increased their stake in the company. Overall, sentiment on the company has been positive, which could be encouraging for potential investors looking to make a move in the stock. Analysts have pointed to McKesson’s strong balance sheet and consistent revenue growth as positive factors, as well as their focus on cost-cutting initiatives and their commitment to expanding into new markets.
On the other hand, some investors have expressed caution due to McKesson’s declining same-store sales and their reliance on Amazon and Walgreens for much of their revenue. Despite these challenges, many analysts remain optimistic about McKesson’s future prospects.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
